@sigmahhz:

𝘚𝘐𝘎𝘔𝘈 𝘏𝘏𝘡
𝘚𝘐𝘎𝘔𝘈 𝘏𝘏𝘡
Open In TikTok:
Region: GB
Saturday 31 October 2026 08:39:17 GMT
8025
184
7
6

Music

Download

Comments

dannychen_1977
Danny Chen :
w Guy
2026-10-31 10:23:49
0
sigmazee1
𝙎𝙄𝙂𝙈𝘼 :
2026-10-31 09:06:36
0
shafayat00.2
BHO🐸✅ :
2026-11-01 07:41:30
0
hamzeyy69
𝙃𝘼𝙈𝙕𝙀𝙔 :
2026-10-31 08:52:52
0
zeso87
𝙀𝙙𝙞𝙩𝙨 :
2026-10-31 09:21:43
0
hacrr666x
hacrr6x :
2026-10-31 09:02:11
0
user274925521
Ismail Khan :
🥰🥰🥰
2026-10-31 08:53:10
0
To see more videos from user @sigmahhz, please go to the Tikwm homepage.

Other Videos

This medication didn’t rise to the top because of strong evidence. It got there through aggressive and unethical marketing that pushed it far beyond its limited FDA-approvals. Gabapentin is now the 7th most prescribed drug in the U.S., despite having only a few approved or evidence-supported uses. Over time, it was framed as a “safer” pain alternative, even as evidence for many uses remained weak. Systematic reviews show statistically significant but clinically trivial reductions in pain and opioid use overall (Anesthesiology 2020), with meaningful benefit limited to a few surgical contexts. What is consistent is harm: combining gabapentin with opioids increases overdose risk due to respiratory depression (PLOS Medicine, 2017), along with higher rates of dizziness, delirium, pneumonia, and antipsychotic use (JAMA 2022). Sources: Wall Street Journal, Gabapentin’s Hidden Risks (Dec 24, 2024) Goodman CW, Brett AS. A Clinical Overview of Off-label Use of Gabapentinoid Drugs. JAMA Internal Medicine, 2019;179(5):695–701. Verret M. Perioperative Use of Gabapentinoids for the Management of Postoperative Acute Pain: A Systematic Review and Meta-Analysis. Anesthesiology, 2020. Park CM. Perioperative Gabapentin Use and In-Hospital Adverse Clinical Events Among Older Adults After Major Surgery. JAMA Internal Medicine, 2022. Gomes T. Gabapentin, Opioids, and the Risk of Opioid-Related Death: A Population-Based Nested Case–Control Study. PLOS Medicine, 2017. #Science #surgeey #doctors #bigpharma #learnontiktok
This medication didn’t rise to the top because of strong evidence. It got there through aggressive and unethical marketing that pushed it far beyond its limited FDA-approvals. Gabapentin is now the 7th most prescribed drug in the U.S., despite having only a few approved or evidence-supported uses. Over time, it was framed as a “safer” pain alternative, even as evidence for many uses remained weak. Systematic reviews show statistically significant but clinically trivial reductions in pain and opioid use overall (Anesthesiology 2020), with meaningful benefit limited to a few surgical contexts. What is consistent is harm: combining gabapentin with opioids increases overdose risk due to respiratory depression (PLOS Medicine, 2017), along with higher rates of dizziness, delirium, pneumonia, and antipsychotic use (JAMA 2022). Sources: Wall Street Journal, Gabapentin’s Hidden Risks (Dec 24, 2024) Goodman CW, Brett AS. A Clinical Overview of Off-label Use of Gabapentinoid Drugs. JAMA Internal Medicine, 2019;179(5):695–701. Verret M. Perioperative Use of Gabapentinoids for the Management of Postoperative Acute Pain: A Systematic Review and Meta-Analysis. Anesthesiology, 2020. Park CM. Perioperative Gabapentin Use and In-Hospital Adverse Clinical Events Among Older Adults After Major Surgery. JAMA Internal Medicine, 2022. Gomes T. Gabapentin, Opioids, and the Risk of Opioid-Related Death: A Population-Based Nested Case–Control Study. PLOS Medicine, 2017. #Science #surgeey #doctors #bigpharma #learnontiktok

About